XML 28 R43.htm IDEA: XBRL DOCUMENT v2.4.0.6
INTANGIBLE ASSETS (Details) (USD $)
3 Months Ended
Mar. 31, 2013
Mar. 31, 2012
Dec. 31, 2012
Finite-Lived Intangible Assets [Line Items]      
Intangible assets, gross $ 9,625,938   $ 9,625,938
Less: accumulated amortization (5,597,114)   (5,479,953)
Intangible assets, net 4,028,824   4,145,985
Amortization expense 117,161 118,463  
Future aggregate amortization expense for intangible assets [Abstract]      
2013 (Nine months) 357,987    
2014 475,148    
2015 475,148    
2016 476,450    
2017 475,148    
2018 & Beyond 1,768,943    
Total 4,028,824    
Patents [Member] | Amlexanox (Aphthasol) [Member]
     
Finite-Lived Intangible Assets [Line Items]      
Intangible assets, gross 2,090,000   2,090,000
Patents [Member] | Amlexanox (OraDiscA) [Member]
     
Finite-Lived Intangible Assets [Line Items]      
Intangible assets, gross 6,873,080   6,873,080
Patents [Member] | OraDisc [Member]
     
Finite-Lived Intangible Assets [Line Items]      
Intangible assets, gross 73,000   73,000
Patents [Member] | Hydrogel Nanoparticle Aggregate [Member]
     
Finite-Lived Intangible Assets [Line Items]      
Intangible assets, gross $ 589,858   $ 589,858